Hyperosmolar hyperglycemic state screening: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
{{CMG}}; {{AE}} {{HS}} | {{CMG}}; {{AE}} {{HS}} | ||
==Overview== | ==Overview== | ||
There is insufficient evidence to recommend routine screening for hyperosmolar hyperglycemic state. | There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for hyperosmolar hyperglycemic state. | ||
==Screening== | ==Screening== | ||
There is insufficient evidence to recommend routine [[Screening (medicine)|screening]] for hyperosmolar hyperglycemic state. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 19:35, 2 October 2017
|
Hyperosmolar hyperglycemic state Microchapters |
|
Differentiating Hyperosmolar hyperglycemic state from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hyperosmolar hyperglycemic state screening On the Web |
|
American Roentgen Ray Society Images of Hyperosmolar hyperglycemic state screening |
|
Risk calculators and risk factors for Hyperosmolar hyperglycemic state screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Husnain Shaukat, M.D [2]
Overview
There is insufficient evidence to recommend routine screening for hyperosmolar hyperglycemic state.
Screening
There is insufficient evidence to recommend routine screening for hyperosmolar hyperglycemic state.